ask="32.95"
ask_size="9000"
average_daily_volume="253498"
bid="N/A"
bid_size="N/A"
book_value="6.63"
change="+0.43"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="0.33"
change_from_52_week_high="-7.64"
change_From_52_week_low="16.28"
change_in_percent="+1.39%"
close="31.28"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.35M"
eps_estimate_current_year="-4.40"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="30861000"
high="31.72"
high_52_weeks="38.92"
last_trade_date="3/10/2017"
last_trade_price="31.28"
last_trade_size="24517"
last_trade_time="4:00pm"
low="30.69"
low_52_weeks="15.00"
market_capitalization="1.65B"
moving_average_200_day="31.32"
moving_average_50_day="30.95"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.86"
open="31.13"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-0.13%"
percent_change_from_50_day_moving_average="+1.07%"
percent_change_from_52_week_high="-19.63%"
percent_change_from_52_week_low="+108.53%"
previous_close="30.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.65"
price_per_sales="33.52"
revenue="48.65M"
shares_outstanding="52855000"
short_ratio="26.94"
stock_exchange="NGM"
symbol="TBPH"
volume="245686"
weeks_range_52="15.00 - 38.92"
